Ascione R, Williams S, Lloyd C T, Sundaramoorthi T, Pitsis A A, Angelini G D
Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom.
J Thorac Cardiovasc Surg. 2001 Apr;121(4):689-96. doi: 10.1067/mtc.2001.112823.
Coronary artery bypass grafting on the beating heart through median sternotomy is a relatively new treatment, which allows multiple revascularization without the use of cardiopulmonary bypass. A prospective randomized study was designed to investigate the effect of coronary bypass with or without cardiopulmonary bypass on postoperative blood loss and transfusion requirement.
Two hundred patients with coronary artery disease were prospectively randomized to (1) on-pump treatment with conventional cardiopulmonary bypass and cardioplegic arrest and (2) off-pump treatment on the beating heart. Postoperative blood loss identified as total chest tube drainage, transfusion requirement, and related costs together with hematologic indices and clotting profiles were analyzed.
There was no difference between the groups with respect to preoperative and intraoperative patient variables. The mean ratio of postoperative blood loss and 95% confidence interval between groups was 1.64 and 1.39 to 1.94, respectively, suggesting on average a postoperative blood loss 1.6 times higher in the on-pump group compared with the off-pump group. Seventy-seven patients in the off-pump group required no blood transfusion compared with only 48 in the on-pump group (P <.01). Furthermore, less than 5% of patients in the on-pump group required fresh frozen plasma and platelet transfusion compared with 30% and 25%, respectively, in the on-pump group (both P <.05). Mean transfusion cost per patient was higher in the on-pump compared with that in the off-pump group ($184.8 +/- $35.2 vs $21.47 +/- $6.9, P <.01).
Coronary artery bypass grafting on the beating heart is associated with a significant reduction in postoperative blood loss, transfusion requirement, and transfusion-related cost when compared with conventional revascularization with cardiopulmonary bypass and cardioplegic arrest.
经正中胸骨切开术在跳动心脏上进行冠状动脉旁路移植术是一种相对较新的治疗方法,它允许在不使用体外循环的情况下进行多次血运重建。一项前瞻性随机研究旨在调查冠状动脉旁路移植术使用或不使用体外循环对术后失血和输血需求的影响。
200例冠心病患者被前瞻性随机分为两组:(1)采用传统体外循环和心脏停搏的体外循环治疗组;(2)跳动心脏上的非体外循环治疗组。分析术后失血(以总胸管引流量确定)、输血需求、相关费用以及血液学指标和凝血指标。
两组患者术前和术中的变量无差异。两组术后失血量的平均比值及95%置信区间分别为1.64以及1.39至1.94,这表明体外循环组术后失血量平均比非体外循环组高1.6倍。非体外循环组77例患者无需输血,而体外循环组仅48例(P<.01)。此外,非体外循环组分别有30%和25%的患者需要新鲜冰冻血浆和血小板输血,而体外循环组均不到5%(均P<.05)。体外循环组每位患者的平均输血费用高于非体外循环组(184.8±35.2美元对21.47±6.9美元,P<.01)。
与采用体外循环和心脏停搏的传统血运重建相比,在跳动心脏上进行冠状动脉旁路移植术可显著减少术后失血、输血需求以及输血相关费用。